RECORD // Company

West Pharmaceutical Services Inc

Formerly: WEST CO INC

Built 2026-11-21T11:32:19Z from public sources · JSON · Open the company profile

ASK THE RECORDS

Ask

COMPANY

Records for this company (8 joined by official identifier)

Every record below is joined to this company by a hard identifier: its SEC registrant record or its GLEIF ownership tree. Each line says how. Built 2026-11-18 13:42:42. Beta: records that match only by name are held apart until name matching is verified.

Gleif lei (7)
SEC EDGAR (1)
Matched by name only, not merged (14)

These records carry the same exact name as this company, but a name alone is not proof, so Seraphix holds them apart until name matching is verified (score due 11-21).

  • WEST LLC · Brla parish businesses · 'West' is an ordinary word shared by many unrelated entities Possible match based on name, not a shared identifier. Compare the records. Compare
  • WEST · East food · 'West' is an ordinary word shared by many unrelated entities Possible match based on name, not a shared identifier. Compare the records. Compare
  • WEST PHARMACEUTICAL SERVICES · Epa echo · exact name match to 'WEST PHARMACEUTICAL SERVICES INC' (no other entity shares the name) Possible match based on name, not a shared identifier. Compare the records. Compare
  • WEST PHARMACEUTICAL SERVICES · Epa echo · exact name match to 'WEST PHARMACEUTICAL SERVICES INC' (no other entity shares the name) Possible match based on name, not a shared identifier. Compare the records. Compare
  • WEST PHARMACEUTICAL SERVICES · Epa echo · exact name match to 'WEST PHARMACEUTICAL SERVICES INC' (no other entity shares the name) Possible match based on name, not a shared identifier. Compare the records. Compare
  • WEST PHARMACEUTICAL SERVICES · Epa echo · exact name match to 'WEST PHARMACEUTICAL SERVICES INC' (no other entity shares the name) Possible match based on name, not a shared identifier. Compare the records. Compare
  • WEST PHARMACEUTICAL SERVICES INC · Epa echo · same registered legal name as 'WEST PHARMACEUTICAL SERVICES INC' Possible match based on name, not a shared identifier. Compare the records. Compare
  • WEST CO THE · Epa rcra · 'West' is an ordinary word shared by many unrelated entities Possible match based on name, not a shared identifier. Compare the records. Compare
  • WEST PHARMACEUTICAL SERVICES, INC. (lobbying via BRYAN CAVE LEIGHTON PAISNER LLP) · LDA lobbying · same registered legal name as 'WEST PHARMACEUTICAL SERVICES INC' Possible match based on name, not a shared identifier. Compare the records. Compare
  • WEST PHARMACEUTICAL SERVICES, INC. (lobbying via CLARK HILL PUBLIC STRATEGIES LLC) · LDA lobbying · same registered legal name as 'WEST PHARMACEUTICAL SERVICES INC' Possible match based on name, not a shared identifier. Compare the records. Compare
  • WEST INC · Sba ppp · 'West' is an ordinary word shared by many unrelated entities Possible match based on name, not a shared identifier. Compare the records. Compare
  • WEST, INC. · Sba ppp · 'West' is an ordinary word shared by many unrelated entities Possible match based on name, not a shared identifier. Compare the records. Compare
  • WEST PHARMACEUTICAL SERVICES INC · Sec cyber · same registered legal name as 'WEST PHARMACEUTICAL SERVICES INC' Possible match based on name, not a shared identifier. Compare the records. Compare
  • WEST PHARMACEUTICAL SERVICES INC · Sec cyber · same registered legal name as 'WEST PHARMACEUTICAL SERVICES INC' Possible match based on name, not a shared identifier. Compare the records. Compare

7 VALUES · 10-Q · EACH LINKS TO ITS FILING

Latest quarter

Latest report: 10-Q for the period ended 2026-09-30, filed 2026-10-29 · accession 0000105770-26-000121

ItemValuePeriodFormFiledAccessionReport
Revenue$874,500,0003 months ended 2026-09-3010-Q2026-10-290000105770-26-0001212026-11-21 11:32 UTCReport an error
Net income (loss)$214,000,0003 months ended 2026-09-3010-Q2026-10-290000105770-26-0001212026-11-21 11:32 UTCReport an error
Interest expense$3,800,0003 months ended 2026-09-3010-Q2026-10-290000105770-26-0001212026-11-21 11:32 UTCReport an error
Cash and cash equivalents$464,100,000at 2026-09-3010-Q2026-10-290000105770-26-0001212026-11-21 11:32 UTCReport an error
Contract liabilities (total)$43,700,000at 2026-09-3010-Q2026-10-290000105770-26-0001212026-11-21 11:32 UTCReport an error
Debt due in the next 12 months (from an earlier report)$0at 2025-12-3110-K2026-02-170000105770-26-0000102026-11-21 11:32 UTCReport an error
Debt due in year 2 (from an earlier report)$203,000,000at 2025-12-3110-K2026-02-170000105770-26-0000102026-11-21 11:32 UTCReport an error

Values as filed in XBRL (SEC company facts); quarterly values are the filer's 3-month figures, never derived.

IDS

Identifiers

SEC CIK
0000105770
Ticker
WST
EIN
231210010
CUSIP
955306105
Record ID
sx:sec:0000105770

OTHER SITES · YOUR CLICK · THEY SHOW THEIR OWN DATA

Open in

Open in…

Each link opens the other site in a new tab, with this company filled in. That site shows its own data under its own terms; Seraphix stores none of it. Seraphix counts clicks per link, nothing about who clicked.

42 FACTS · EACH LINKS TO ITS FILING

Facts

FactValueAs ofSourceRetrievedReport
SEC entity typeoperating2026-11-05SEC EDGAR company profile2026-11-21 11:32 UTCReport an error
SIC industry3841 Surgical & Medical Instruments & Apparatus2026-11-05SEC EDGAR company profile2026-11-21 11:32 UTCReport an error
State of incorporationPA2026-11-05SEC EDGAR company profile2026-11-21 11:32 UTCReport an error
Fiscal year end (MMDD)12312026-11-05SEC EDGAR company profile2026-11-21 11:32 UTCReport an error
Business address530 HERMAN O. WEST DRIVE, EXTON, PA, 193412026-11-05SEC EDGAR company profile2026-11-21 11:32 UTCReport an error
ExchangesNYSE2026-11-05SEC EDGAR company profile2026-11-21 11:32 UTCReport an error
Revenue (fiscal year ended 2025-12-31)$3,074,100,0002025-12-3110-K, XBRL RevenueFromContractWithCustomerExcludingAssessedTax2026-11-21 11:32 UTCReport an error
Net income (loss) (fiscal year ended 2025-12-31)$493,700,0002025-12-3110-K, XBRL NetIncomeLoss2026-11-21 11:32 UTCReport an error
Total assets (at 2025-12-31)$4,270,000,0002025-12-3110-K, XBRL Assets2026-11-21 11:32 UTCReport an error
Stockholders' equity (at 2025-12-31)$3,176,000,0002025-12-3110-K, XBRL StockholdersEquity2026-11-21 11:32 UTCReport an error
Cash and cash equivalents (at 2025-12-31)$791,300,0002025-12-3110-K, XBRL CashAndCashEquivalentsAtCarryingValue2026-11-21 11:32 UTCReport an error
Operating cash flow (fiscal year ended 2025-12-31)$754,800,0002025-12-3110-K, XBRL NetCashProvidedByUsedInOperatingActivities2026-11-21 11:32 UTCReport an error
Capital expenditures (property, plant and equipment) (fiscal year ended 2025-12-31)$285,900,0002025-12-3110-K, XBRL PaymentsToAcquirePropertyPlantAndEquipment2026-11-21 11:32 UTCReport an error
Long-term debt (at 2025-12-31)$202,800,0002025-12-3110-K, XBRL LongTermDebt2026-11-21 11:32 UTCReport an error
Operating lease liabilities (at 2025-12-31)$118,300,0002025-12-3110-K, XBRL OperatingLeaseLiability2026-11-21 11:32 UTCReport an error
Unrecorded purchase obligations (at 2025-12-31)$221,800,0002025-12-3110-K, XBRL UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount2026-11-21 11:32 UTCReport an error
8-K Item 2.02, Results of Operations and Financial Condition (filed 2026-10-29)On October 29, 2026, West Pharmaceutical Services, Inc. (the “Company”) issued a press release announcing its third-quarter 2026 financial results. A copy of the press release is attached hereto as Exhibit 99.1 and incorporated herein by reference.2026-10-29SEC EDGAR 8-K 0000105770-26-000118 (text as filed, excerpt)2026-11-21 11:32 UTCReport an error
8-K Item 7.01, Regulation FD Disclosure (filed 2026-10-29)The information set forth in “Item 2.02 Results of Operations and Financial Condition,” including the exhibit referred to therein, is incorporated herein by reference. A copy of the Company’s presentation materials used during the call will be available through the Investors link at the Company’s website, http://www.westpharma.com, and is also attached hereto as Exhibit 99.2 and incorporated herein by reference. The information in this report (including the exhibits attached hereto) is being furnished pursuant to Item 2.02 and Item 7.01 and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (“Exchange Act”), or otherwise subject to the…2026-10-29SEC EDGAR 8-K 0000105770-26-000118 (text as filed, excerpt)2026-11-21 11:32 UTCReport an error
8-K Item 1.01, Entry Into a Material Definitive Agreement (filed 2026-10-26)The information contained in Item 2.03 below is incorporated herein by reference.2026-10-26SEC EDGAR 8-K 0000105770-26-000114 (text as filed, excerpt)2026-11-21 11:32 UTCReport an error
8-K Item 1.02, Termination of a Material Definitive Agreement (filed 2026-10-26)2019 Credit Agreement On October 26, 2026 (the “Effective Date”), West Pharmaceutical Services, Inc., a Pennsylvania corporation (the “Company”), (i) used a portion of the proceeds from borrowings under the New Credit Agreement (as defined and described in Item 2.03 below) to prepay the amounts outstanding under that certain Credit Agreement, dated as of March 28, 2019 (as amended, restated, extended, supplemented or otherwise modified from time to time prior to the Effective Date, the “Existing Credit Agreement”), among the Company, the other borrowers party thereto, Bank of America, N.A., as administrative agent, and the banks and financial institutions from time to time parties thereto…2026-10-26SEC EDGAR 8-K 0000105770-26-000114 (text as filed, excerpt)2026-11-21 11:32 UTCReport an error
8-K Item 2.03, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant (filed 2026-10-26)On the Effective Date, the Company entered into a new financing agreement, as described herein. All references herein to “dollars” or “$” are to U.S. dollars. New Credit Agreement On the Effective Date, the Company, the other borrowers party thereto, Bank of America, N.A., as administrative agent, swing line lender and an issuing lender, and the other lenders from time to time party thereto (the “Lenders”) entered into that certain Credit Agreement (as amended, restated, extended, supplemented or otherwise modified from time to time, the “New Credit Agreement”), pursuant to which the applicable Lenders made loans and other credit extensions to the Company under a revolving credit facility…2026-10-26SEC EDGAR 8-K 0000105770-26-000114 (text as filed, excerpt)2026-11-21 11:32 UTCReport an error
Employer name (as filed)West Pharmaceutical Services, Inc.2026-06-30DOL OFLC LCA Disclosure Data (dataset)2026-11-21 11:32 UTCReport an error
Certified LCAs72026-06-30DOL OFLC LCA Disclosure Data (dataset)2026-11-21 11:32 UTCReport an error
Certified LCAs later withdrawn02026-06-30DOL OFLC LCA Disclosure Data (dataset)2026-11-21 11:32 UTCReport an error
Total worker positions on certified LCAs72026-06-30DOL OFLC LCA Disclosure Data (dataset)2026-11-21 11:32 UTCReport an error
Top job titles (title, LCA count)Senior Quality Engineer (2); Principal Solution Architect - D&T, SAP Plant Maintenance (1); Manager, Regulatory Affairs (1); Quality Systems Manager (1); Quality Engineer (1)2026-06-30DOL OFLC LCA Disclosure Data (dataset)2026-11-21 11:32 UTCReport an error
Wage offered, annualized (n, min, median, max)median $105,227 (range $90,771-$127,400, 7 filings)2026-06-30DOL OFLC LCA Disclosure Data (dataset)2026-11-21 11:32 UTCReport an error
Worksite statesAZ; PA2026-06-30DOL OFLC LCA Disclosure Data (dataset)2026-11-21 11:32 UTCReport an error
Plan (pension, plan no. 008)WEST PHARMACEUTICAL SERVICES, INC. 401(K) PLAN: 5,271 participants, assets $574,465,6642025-12-31DOL EBSA Form 5500 public datasets (dataset)2026-11-21 11:32 UTCReport an error
Plan (welfare, plan no. 501)WEST PHARMACEUTICAL SERVICES, INC. WELFARE PLAN: 3,575 participants2025-12-31DOL EBSA Form 5500 public datasets (dataset)2026-11-21 11:32 UTCReport an error
Plan (welfare, plan no. 503)WEST PHARMACEUTICAL SERVICES, INC. HEALTH REIMBURSEMENT ARRANGEMENT FOR MEDICARE ELIGIBLE RETIREES: 290 participants2025-12-31DOL EBSA Form 5500 public datasets (dataset)2026-11-21 11:32 UTCReport an error
Plan (welfare, plan no. 504)WEST PHARMACEUTICAL SERVICES, INC. SEVERANCE PAY PLAN: 15 participants2025-12-31DOL EBSA Form 5500 public datasets (dataset)2026-11-21 11:32 UTCReport an error
Largest institutional holder #1 (13F as filed): BlackRock, Inc.$2,387,990,3732026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-21 11:32 UTCReport an error
Largest institutional holder #2 (13F as filed): VANGUARD CAPITAL MANAGEMENT LLC$1,656,115,1062026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-21 11:32 UTCReport an error
Largest institutional holder #3 (13F as filed): VANGUARD PORTFOLIO MANAGEMENT LLC$1,441,659,9942026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-21 11:32 UTCReport an error
Largest institutional holder #4 (13F as filed): FMR LLC$1,283,358,8712026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-21 11:32 UTCReport an error
Largest institutional holder #5 (13F as filed): STATE STREET CORP$1,202,182,5822026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-21 11:32 UTCReport an error
Largest institutional holder #6 (13F as filed): Artisan Partners Limited Partnership$865,833,4832026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-21 11:32 UTCReport an error
Largest institutional holder #7 (13F as filed): Bank of New York Mellon Corp$733,732,6102026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-21 11:32 UTCReport an error
Largest institutional holder #8 (13F as filed): GENERATION INVESTMENT MANAGEMENT LLP$728,167,5982026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-21 11:32 UTCReport an error
Largest institutional holder #9 (13F as filed): GEODE CAPITAL MANAGEMENT, LLC$680,551,5902026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-21 11:32 UTCReport an error
Largest institutional holder #10 (13F as filed): JPMORGAN CHASE & CO$413,034,6442026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-21 11:32 UTCReport an error

EVERY DATED RECORD, NEWEST FIRST

Timeline

WHAT IS NOT HERE

Gaps

SOURCES AND LICENSE

Sources

CC BY 4.0 -- credit Seraphix Systems.

API

Use this record

Records are free to read and reuse under CC BY 4.0 -- credit Seraphix Systems. The same records as JSON: GET /v1/search?q= and GET /v1/record/<id> (without a key, up to 50 record lookups a day per visitor). No key: single records, pages, feeds and bulk files are free; cross-company search and the live stream cost $0.002 a call via x402. Free key: 100 calls a month, no card. Get a free key or a paid key; send Authorization: Bearer <key>.